Lisa Garrison
Director, Payment Integrity, Business Solutions
Abacus Insights
Rosalind Holmes
Patent Attorney
Boehringer Ingelheim
Dr. Rosalind M. Holmes is a Patent Attorney at Boehringer Ingelheim responsible for global patent, license and contract matters in the new chemical entity team, particularly for Immunology & Respiratory programs. Originally from the UK, Rosalind has a doctorate in DNA repair mechanisms and in 2008 was trained in IP law by a Frenchman at an American company in Germany. Her career to-date spans (bio)pharmaceuticals, biosimilars, cosmetics and excipients. In addition to her qualification in European patent litigation from the Politecnico di Milano, Rosalind is also a Solicitor of England & Wales and a certified AI Governance Professional.
How MedTech companies decide when to patent device innovation and when to rely on trade secret protection, balancing enforcement leverage, disclosure risk, and reverse engineering realities.
Gabriel Olander
Associate GC, IP Strategy
Intuitive
Michael Doyle
Chief IP Officer
ICU Medical
Josefina Correa
Chief Executive Officer
Xeptiva Therapeutics
Josefina Correa
Chief Executive Officer
Xeptiva Therapeutics
Dr Gary Call
Chief Medical Officer
HMS
Dr. Gary Call is a board-certified family physician and senior healthcare executive with extensive experience in managed care operations and payment integrity.
Dr. Call is nationally recognized for his leadership in payment integrity and FWA prevention, including advanced analytics, clinical review strategies, and technology-enabled solutions that protect both government and commercial payer programs from improper payments and emerging integrity risks.
As Chief Medical Officer at HMS, Dr. Call oversees Payment Integrity, Care Management, Clinical Analytics, and Population Health Solutions, driving innovation and clinical programs that improve outcomes, strengthen program integrity, and support the financial sustainability of state healthcare programs.
Jordan Grotzinger
Shareholder
Greenberg Traurig, LLP